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h-prune, which has been suggested to be involved in cell migration, was identified as a glycogen synthase
kinase 3 (GSK-3)-binding protein. Treatment of cultured cells with GSK-3 inhibitors or small interfering RNA
(siRNA) for GSK-3 and h-prune inhibited their motility. The kinase activity of GSK-3 was required for the
interaction of GSK-3 with h-prune. h-prune was localized to focal adhesions, and the siRNA for GSK-3 or
h-prune delayed the disassembly of paxillin. The tyrosine phosphorylation of focal adhesion kinase (FAK) and
the activation of Rac were suppressed in GSK-3 or h-prune knocked-down cells. GSK-3 inhibitors suppressed
the disassembly of paxillin and the activation of FAK and Rac. Furthermore, h-prune was highly expressed in
colorectal and pancreatic cancers, and the positivity of the h-prune expression was correlated with tumor
invasion. These results suggest that GSK-3 and h-prune cooperatively regulate the disassembly of focal
adhesions to promote cell migration and that h-prune is useful as a marker for tumor aggressiveness.
The serine/threonine kinase glycogen synthase kinase 3
(GSK-3) was first described for a metabolic pathway for gly-
cogen synthase regulation that is sensitive to insulin-mediated
inhibition (35). GSK-3 has subsequently been shown to regu-
late several physiological responses, including protein synthe-
sis, gene expression, subcellular localization of proteins, and
protein degradation, in mammalian cells by phosphorylating
many substrates (5, 9, 16). There are two members of GSK-3
and GSK-3 in mammals (49). GSK-3 is highly conserved
through evolution and plays a fundamental role in cellular
responses. For example, there are four genes, MCK1, MDS1/
RIM11, MRK1, and YOL128c, which encode homologs of
mammalian GSK-3 in Saccharomyces cerevisiae. Mck1 stabi-
lizes Rog1 (1) and stimulates gene expression by Msn2 in
yeasts (19).
To understand the molecular mechanism by which GSK-3
recognizes specific target substrates, we have tried to isolate
proteins that bind to GSK-3. So far, we have identified Axin,
Axil, and AKAP220 as GSK-3-binding proteins (21, 43, 52).
Axin binds to not only GSK-3 but also -catenin, APC, and
Dvl, all of which are important components in the Wnt signal-
ing pathway (25, 48). In the Axin complex, GSK-3 phosphor-
ylates -catenin, APC, and Axin efficiently (21, 27) and thereby
induces ubiquitination of -catenin, leading to its degradation.
Axil has characteristics similar to those of Axin (52). AKAP220
binds to not only GSK-3 but also cyclic AMP (cAMP)-depen-
dent protein kinase and protein phosphatase 1 (43). The phos-
phorylation and dephosphorylation of GSK-3 occur efficiently
in the AKAP220 complex. Therefore, GSK-3 may exhibit dif-
ferent functions and regulation depending on its binding part-
ners.
Evidence that GSK-3 regulates cellular architecture in neu-
ronal cells has been accumulated (5, 24). Two microtubule-
associating proteins, Tau and MAP1B, are phosphorylated by
GSK-3, which regulates their binding to microtubules, thereby
modulating microtubule dynamics. An inactive pool of GSK-3
has been found to be localized at the leading edge of the cells
alongside F-actin, and semapholin 3A and lysophosphatidic
acid activate GSK-3, causing growth cone collapse and neurite
retraction (10). GSK-3 mediates Par6-PKC-dependent pro-
motion of polarization and cell protrusion in astrocytes (11).
Furthermore, GSK-3 phosphorylates CRMP2 to specify the
fate of axons and dendrites (54). GSK-3 has also been shown to
be involved in signaling activated by cell adhesion in nonneu-
ronal cells (23, 37). The formation of extending lamellipodia in
migrating keratinocytes is blocked by GSK-3 inhibitors (29).
The initiation and stimulation of sperm motility are accompa-
nied by the inactivation of GSK-3 (41). Although these results
suggest that GSK-3 is involved in the dynamics of actin fila-
ments and microtubules, how the GSK-3 activity is linked to
molecules involved in cell migration is not clearly understood.
The human homolog of Drosophila prune protein (h-prune)
belongs to the DHH superfamily of phosphodiesterases
(PDE), which have cytoplasmic cyclic nucleotide phosphodies-
terase activity (8). Overexpression of h-prune in cultured cells
is involved in promoting cellular motility, and inhibition of
PDE activity by a PDE inhibitor suppresses h-prune-induced
motility (8). Consistent with these observations, overexpres-
sion of h-prune in breast cancer is correlated with cancer
progression and aggressiveness (55). However, the molecular
mechanism by which h-prune regulates cell motility remains to
be defined.
To understand the molecular mechanism by which GSK-3
regulates cell migration, we screened new GSK-3-binding pro-
teins. Here, we identified h-prune as a GSK-3-binding protein.
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Knockdown of GSK-3 and h-prune by small interfering RNA
(siRNA) suppressed cell migration. h-prune formed a complex
with paxillin and vinculin at focal adhesions. Loss of activity of
GSK-3 or knockdown of GSK-3 and h-prune inhibited the
disassembly of paxillin, the tyrosine phosphorylation of focal
adhesion kinase (FAK), and the activation of Rac. These re-
sults indicate that GSK-3 and h-prune cooperatively regulate
the disassembly of focal adhesions to regulate cell migration.
MATERIALS AND METHODS
Materials and chemicals. HeLa S3 and C57MG cells were provided by K.
Matsumoto (Nagoya University, Nagoya, Japan) and S. Takada (National Insti-
tutes of Natural Sciences, Okazaki, Japan), respectively. Human GSK-3 cDNA
was provided by J. R. Woodgett (Ontario Cancer Institute, Toronto, Canada).
Recombinant baculoviruses expressing glutathione S-transferase (GST)-fused
h-prune wild type (WT) were generated by Y. Matsuura (Osaka University,
Suita, Japan). Paxillin cDNA and pGEX-PAK-CRIB were provided by H. Sabe
(Osaka Bioscience Institute, Osaka, Japan) and K. Kaibuchi (Nagoya University,
Nagoya, Japan), respectively. Green fluorescent protein (GFP)-tagged Super-
FAK (the K578E/K581E mutant) was provided by M. D. Schaller (University of
North Carolina, Chapel Hill, NC) (15). HeLa S3 cells stably expressing h-prune
(WT) or amino acid region 199 to 453 of h-prune [h-prune(199-453)] were
generated by selection with G418. NIH 3T3 and HeLa S3 cells stably expressing
GFP-paxillin were generated by selection with puromycin. The anti-Myc anti-
body was prepared from 9E10 cells. The anti-h-prune antibody was prepared in
rabbits by immunization with recombinant h-prune(199-453) proteins. siRNA
duplexes used were as follows: human GSK-3 (sense), 5-GAAGGUUCUCC
AGGACAAGTT-3; human GSK-3 (sense), 5-AGUUAGCAGAGACAAGG
ACTT-3; mouse GSK-3 (sense), 5-GAAGUCUAGCCUAUAUCCATT-3;
h-prune (sense), 5-GGCGUCAAGGUGGCCAUUATT-3; and human casein
kinase I (CKI) (sense), 5-CCAGGCAUCCCCAGUUGCUTT-3. Other ma-
terials were from commercial sources.
Plasmid construction. pCGN/GSK-3 (WT), pCGN/GSK-3 K85M, pCGN/
GSK-3 K85R, pCGN/GSK-3 Y216F, pCGN/GSK-3 S9A, and pGEX-4T/
GSK-3 (WT) were constructed as previously described (21, 43). Standard re-
combinant DNA techniques were used to construct the following plasmids:
pEF-BOS-Myc/h-prune (WT), pEF-BOS-Myc/h-prune(1-332), pEF-BOS-Myc/
h-prune(199-453), pEF-BOS-Myc/h-prune(333-453), pGEX-6P/h-prune (WT),
pV-IKS/h-prune (WT), pAd-CMV-Myc/h-prune (WT), and pRSETA/GSK-3
(WT).
Cell culture. COS, NIH 3T3, and HeLa S3 cells were grown in Dulbecco’s
modified Eagle’s medium supplemented with 10% calf serum and 10% fetal
bovine serum (FBS). C57MG cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS and 10 g/ml insulin. SW480 and CHO
cells were grown in RPMI medium and Ham’s F-12 medium supplemented with
10% FBS, respectively. When necessary, the cells were treated with 3 to 10 M
SB216763 for 4 h or 10 to 30 mM LiCl for 12 h or transfected with the siRNA
for GSK-3 or h-prune.
Cell migration assay. To measure the cell migration activity, Transwell and
wound-healing assays were performed. The Transwell cell migration assay was
performed using a modified Boyden chamber (tissue culture treated, 6.5-mm
diameter, 10-m thickness, 8-m pores; Transwell) (Costar, Cambridge, MA) as
described previously (20, 32). The haptotactic migration assay was done by
coating only the lower surface of the polycarbonate membrane with 10 g/ml
collagen or fibronectin, whereas the random migration assay was done by coating
both the upper and lower surfaces of the membrane with 0.1 g/ml collagen.
HeLa S3, SW480, and CHO cells (2.5  104 cells) and NIH 3T3 cells (2.5  105
cells) suspended in serum-free medium containing 0.1% bovine serum albumin
with or without inhibitors were applied to the upper chamber and allowed to
migrate to the lower side of the upper chamber for 2 to 12 h. The numbers of the
cells that migrated to the lower side of the upper chamber were counted, and
relative cell migration was expressed as the percentage of migrated cells with
treatment compared to those without treatment.
To carry out the wound-healing assay, HeLa S3, C57MG, NIH 3T3, and
SW480 cells were plated onto collagen- or fibronectin-coated coverslips. The
monolayer cells were then scratched manually with a plastic pipette tip, and after
being washed with phosphate-buffered saline, wounded monolayers of the cells
were allowed to heal for 12 to 24 h.
Immunohistochemistry. The immunocytochemical analyses of the cultured
cells were performed as described previously (51) except that the cultured cells
were simultaneously fixed and permeabilized with phosphate-buffered saline
containing 3.7% paraformaldehyde and 0.5% Triton X-100. The immunohisto-
chemical analyses of paraffin-embedded tissues from patients were performed as
previously described (30). The sections were counterstained with 0.1% hema-
toxylin. A result was considered positive when more than 50% of the cells were
stained.
Clinicopathological analyses of h-prune. For immunohistochemical analyses,
we used archival formalin-fixed, paraffin-embedded tissues from 134 patients
who had undergone surgical excision for colorectal cancer (adenocarcinoma) (n
 92) or pancreatic cancer (ductal adenocarcinoma) (n  42). Tumor staging
was carried out according to the TNM staging system (40). The procedure to
protect privacy was in accordance with the Ethical Guidelines for Human Ge-
nome/Gene Research enacted by the Japanese government. Correlations be-
tween clinicopathologic parameters and h-prune expression were analyzed by
Fisher’s exact test. P values less than 0.05 were considered statistically significant.
Live imaging of adhesion and lamellipodia. The dynamics of GFP-paxillin of
the scratched monolayer cells were quantified as described previously (14, 46).
Fluorescence intensities of individual adhesions from background-subtracted
images were measured over time using MetaMorph software (Universal Imaging
Corporation, Downingtown, PA). For rate constant measurements, periods of
disassembly (decreasing fluorescence intensity) of adhesions containing GFP-
paxillin were plotted on separate semilogarithmic graphs representing fluores-
cence intensity ratios over time. Semilogarithmic plots of fluorescence intensities
as a function of time were generated using the formula ln (I0/I) for disassembly,
where I0 is the initial fluorescence intensity and I is the fluorescence intensity at
various time points. The slopes of linear regression trend lines fitted to the
semilogarithmic plots were then calculated to determine apparent rate constants
of disassembly. For each rate constant, measurements were made on at least 10
individual adhesions in five separate cells. For lamellipodium formation, images
were captured at 5-min intervals for 60 min. The average area of protrusion
(m2) per 5-min interval was calculated. Measurements were made with at least
five separate cells (7).
Others. Yeast two-hybrid screening was carried out as previously described
(21, 52). Immunoprecipitation assays and RNA interference (RNAi) were per-
formed as described previously (18, 51). The GSK-3 activity was assayed by the
use of synthetic peptides as substrates (21, 43). The PDE activity of HeLa S3 cells
was assayed using [3H]cAMP as a substrate (44). Activation of Rac was assayed
using GST-CRIB (2).
RESULTS
Involvement of GSK-3 in cell migration. First, we examined
the involvement of GSK-3 in cell motility using a Transwell
migration assay. HeLa S3 cells migrated over both collagen
and fibronectin (Fig. 1A). LiCl, which is known to inhibit
GSK-3 activity (28, 42), reduced the migration of HeLa S3
cells, but NaCl did not affect the migration (Fig. 1A).
SB216763, which is another GSK-3 inhibitor, also suppressed
the migration (Fig. 1A). CHO cells migrated over fibronectin
but not collagen, and LiCl reduced the migration (Fig. 1B).
Overexpression of wild-type GSK-3 or a constitutively active
form of GSK-3 did not affect cell migration (data not shown),
indicating that GSK-3 is not a limiting factor for migration.
We depleted endogenous GSK-3 in HeLa S3 cells by RNAi
to find whether GSK-3 is definitively involved in the regulation
of cell migration. An siRNA for GSK-3 or GSK-3 reduced
the respective levels but not the levels of vinculin and CKI
(Fig. 1C). A single-stranded sense oligonucleotide for GSK-3
or siRNA for CKI did not affect the protein levels of GSK-3
and GSK-3 (Fig. 1C). A decrease of either GSK-3 or
GSK-3 but not CKI inhibited the migration of HeLa S3 cells
(Fig. 1C). Since these assays were done by coating the lower
surface of the membranes with substrates, these results indi-
cate the involvement of GSK-3 in haptotaxis. Random migra-
tion was measured by coating both the upper and lower sur-
faces of the membrane with the substrates. Inhibition of
GSK-3 also suppressed the random migration of HeLa S3 cells
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(Fig. 1D). Therefore, GSK-3 is involved in both haptotactic
and random migration. In the following experiments, we used
a haptotactic assay. Inhibition of GSK-3 by LiCl in CHO cells
and reduction of GSK-3 by RNAi in HeLa S3 cells did not
inhibit cell adhesiveness (data not shown).
Identification of h-prune as a GSK-3-binding protein. To
identify GSK-3-binding proteins that are involved in cell mi-
gration, we screened a human brain cDNA library using the
yeast two-hybrid method. A 1.8-kb cDNA insert was found to
carry a sequence containing an open reading frame for h-prune
(Fig. 2A). h-prune belongs to the DHH family and exhibits
PDE activity, and overexpression of h-prune enhances cell
migration, which is inhibited by the suppression of its PDE
activity (8).
Reciprocal immunoprecipitation analyses showed that
GSK-3 and h-prune formed a complex at the endogenous
level in HeLa S3 cells (Fig. 2B). GSK-3 also formed a com-
plex with h-prune (Fig. 2B). In vitro binding studies using
recombinant proteins demonstrated that GSK-3 bound di-
rectly to h-prune (Fig. 2C). Amino acid region 333 to 453 of
h-prune was necessary and sufficient for the complex formation
with GSK-3 in intact cells (Fig. 2D). Treatment of HeLa S3
cells with GSK-3 inhibitors decreased the formation of a com-
plex between GSK-3 and h-prune (Fig. 2E). Furthermore,
GSK-3 kinase-inactive mutants (the K85M, K85R, and
Y216F mutants) did not form a complex with h-prune under
the conditions in which wild-type GSK-3 and a constitutively
active GSK-3 mutant (S9A) did (Fig. 2F). These results in-
dicate that the kinase activity of GSK-3 is required for its
interaction with h-prune in intact cells. GSK-3 did not phos-
phorylate h-prune in vitro, and SB216763 did not affect the
phosphorylation of h-prune in intact cells, where 32P was met-
abolically labeled (data not shown). h-prune does not possess
the typical consensus sequences for phosphorylation by GSK-3.
Therefore, it is unlikely that h-prune is a substrate of GSK-3.
The kinase activity of GSK-3 in the h-prune immune com-
FIG. 1. Involvement of GSK-3 in cell migration. (A) HeLa S3 cells treated with the indicated inhibitors were subjected to the Transwell
migration assay. (B) CHO cells treated with NaCl or LiCl were subjected to the Transwell migration assay. (C) Left panel, the lysates of HeLa
S3 cells transfected with the indicated siRNAs were probed with the indicated antibodies. Right panel, HeLa S3 cells transfected with the indicated
siRNAs were subjected to the Transwell migration assay. A single-strand RNA for GSK-3 was used as a control. (D) HeLa S3 cells treated with
SB216763 were subjected to the random migration assay. The results shown are means 	 standard errors of the means from four independent
experiments. DMSO, dimethyl sulfoxide; Na, NaCl; Li, LiCl; SB, SB216763; no treat, no treatment.
FIG. 2. Interaction of h-prune with GSK-3. (A) Schematic representation of the deletion mutants of h-prune used in this study. (B) The lysates
of HeLa S3 cells (lanes 1 and 6) were immunoprecipitated with anti-GSK-3 or anti-h-prune antibody, and the immunoprecipitates were probed
with the indicated antibodies (lanes 3, 5, and 8). The immunoprecipitates formed with anti-Myc and anti-GFP antibodies were used as controls
(lanes 2, 4, and 7). GSK-3/ Ab is an antibody that recognizes both GSK-3 () and GSK-3 (). (C) Recombinant His6-GSK-3, GST-h-prune,
and GST (0.5 g of protein) were stained with Coomassie brilliant blue (lanes 1 to 3). After 0.4 M His6-GSK-3 was incubated with 0.5 M
GST-h-prune or GST immobilized on glutathione-Sepharose in 100 l of reaction mixture (20 mM Tris/HCl, pH 7.5, and 1 mM dithiothreitol) for
1 h at 4°C, GST-h-prune and GST were precipitated by centrifugation, and then the precipitates were probed with the anti-His6 antibody (lanes
4 to 6). (D) The lysates of COS cells expressing the deletion mutants of Myc-h-prune were probed with anti-GSK-3 or anti-Myc antibody (lanes
1 to 5). The same lysates were immunoprecipitated with anti-Myc antibody, and the immunoprecipitates were probed with the indicated antibodies
(lanes 6 to 10). (E) HeLa S3 cells treated with 10 M SB216763 or 30 mM LiCl were lysed, and the lysates were probed with anti-GSK-3 or
anti-h-prune antibody (lanes 1 to 4). The same lysates were immunoprecipitated with anti-GSK-3 (lanes 5 to 6) or anti-h-prune antibody (lanes
7 to 10), and the immunoprecipitates were probed with the indicated antibodies. The lower bands detected by anti-h-prune antibody in Fig. 2B
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and E are nonspecific bands. (F) The lysates of COS cells expressing HA–GSK-3 mutants and Myc-h-prune were probed with anti-HA or
anti-Myc antibody (lanes 1 to 7). The same lysates were immunoprecipitated with anti-Myc antibody, and the immunoprecipitates were probed with
the indicated antibodies (lanes 8 to 13). (G) Left panel, the kinase activity of GSK-3 in the immunoprecipitates from HeLa S3 cells with
anti-h-prune antibody was measured in the presence or absence of SB216763 in vitro. Right panel, the lysates of HeLa S3 cells expressing
Myc-h-prune were immunoprecipitated with anti-Myc or anti-HA antibody, and the immunoprecipitates were probed with anti-GSK-3 antibody
and the phospho-specific antibody to GSK-3 Tyr216 (pY216-GSK-3). (H) The PDE activity of h-prune in HeLa S3 cells was measured after
treatment with SB216763 in intact cells or with IBMX in vitro. (I) After HeLa S3 cells were treated with 10 M dipyridamole for 4 h, h-prune was
immunoprecipitated from the lysates and the immunoprecipitates were probed with anti-GSK-3 and anti-h-prune antibodies. HA, hemagglutinin;
IP, immunoprecipitation; Ab, antibody; SB, SB216763; Dip, dipyridamole; Ig, immunoglobulin; DMSO, dimethyl sulfoxide; no treat, no treatment;
Mock, control.
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plexes was detected using peptide substrates, and the Tyr216-
phosphorylated form of GSK-3, which is an active form, was
observed in the h-prune immune complexes (Fig. 2G), indicat-
ing that GSK-3 complexed with h-prune is active. The PDE
activity in the h-prune immune complexes from HeLa S3 cells
expressing h-prune was measured using [3H]cAMP as a sub-
strate. This activity was indeed inhibited by 3-isobutyl-1-meth-
ylxanthine (IBMX), a well-known PDE inhibitor. However, the
PDE activity was not affected by the treatment of HeLa S3 cells
with GSK-3 inhibitors (Fig. 2H). Therefore, the kinase activity
of GSK-3 is not required for the PDE activity of h-prune.
Dipyridamole was shown to inhibit the PDE activity (8). Treat-
ment of HeLa S3 cells with dipyridamole did not affect the
complex formation between h-prune and GSK-3 (Fig. 2I),
suggesting that the PDE activity of h-prune is not necessary for
the binding of h-prune to GSK-3.
Involvement of h-prune in cell migration. An siRNA for
h-prune suppressed cell motility in the Transwell migration
assay (Fig. 3A), indicating that h-prune is necessary for cell
migration. Expression of the C-terminal region of Myc-h-
prune in HeLa S3 cells inhibited the formation of a complex of
GSK-3 with h-prune at the endogenous levels, and the cells
expressing the Myc-h-prune mutant (C1 and C33) exhibited
slow migration (Fig. 3B). These results suggest that the binding
of GSK-3 and h-prune is involved in cell migration.
Localization of h-prune to focal adhesions. To clarify the
mode of regulation of cell migration by GSK-3 and h-prune,
the subcellular localization of these proteins was examined.
GSK-3 was observed to be localized along with stress fibers in
HeLa S3 cells when the cells were treated with 0.5% Triton
X-100 to remove soluble proteins (Fig. 4A, a to c). h-prune was
located at focal adhesions at the cell bottom, where paxillin
was present, and these two proteins were colocalized (Fig. 4A,
d to f). Similar subcellular localizations of these two proteins
were also observed in C57MG mouse mammary gland cells
(Fig. 4B, a to c and m to o). GSK-3 was located to stress
fibers, and GSK-3 on the ends of stress fibers was colocalized
with paxillin at focal adhesions (Fig. 4B, a to f). Furthermore,
the Tyr216-phosphorylated form of GSK-3 was present at the
terminal regions of stress fibers (Fig. 4B, g to i), consistent with
previous observations (3). h-prune was observed on the ends of
stress fibers at focal adhesions and colocalized with paxillin
(Fig. 4B, j to o). h-prune and GSK-3 were partially colocalized
to the ends of stress fibers at focal adhesions (Fig. 4B, p to r).
h-prune and vinculin, another focal adhesion protein, were
also clearly colocalized to focal adhesions at the cell bottom
(data not shown). Consistent with these results, immunopre-
cipitation assays demonstrated that h-prune is associated with
paxillin and vinculin in addition to GSK-3 at the endogenous
levels in HeLa S3 (data not shown) and C57MG (Fig. 4C) cells.
Myc-h-prune(1-332) but not Myc-h-prune(333-453) or Myc-h-
prune(199-453) interacted with paxillin (Fig. 4D), indicating
that GSK-3 and paxillin form a complex with different regions
of h-prune. Furthermore, recombinant GST-paxillin precipi-
tated h-prune, vinculin, and GSK-3 from the HeLa S3 cells
expressing Myc-h-prune (Fig. 4E). Taken together, these re-
sults suggest that h-prune links active GSK-3 to focal adhe-
sions.
Involvement of GSK-3 and h-prune in formation of focal
adhesions. The scratch wound migration assay was performed
to examine the roles of GSK-3 and h-prune in the formation of
focal adhesions. C57MG cells were allowed to migrate in
scratch wound cultures, resulting in wound closure after 12 h,
which was inhibited by SB216763 (Fig. 5A). Paxillin and vin-
culin were observed clearly in control migrating cells, and
h-prune was colocalized with them (Fig. 5B, a to c and j to l).
Large focal adhesions, including paxillin, vinculin, and
h-prune, were formed at a leading edge of the cells treated with
SB216763 (Fig. 5B, d to f, m to o). These proteins seemed to
be accumulated at focal adhesions in the treated cells com-
pared with control cells. Dipyridamole did not affect the sub-
cellular localization of paxillin and h-prune (Fig. 5B, g to i),
indicating that the PDE activity is not required for the local-
ization of h-prune to focal adhesions. h-prune accumulated in
the cells treated with SB216763 was localized to the tips of
actin fibers (data not shown). To perform similar experiments
with RNAi, we analyzed HeLa S3 cells. At the cell front along
the leading edge of migrating HeLa S3 cells, weak staining of
paxillin and vinculin was detected and little h-prune was ob-
served (Fig. 5C, a to c and g to i). GSK-3 knocked-down cells
exhibited the accumulation of paxillin, vinculin, and h-prune at
focal adhesions (Fig. 5C, d to f and j to l).
Inhibition of GSK-3 activity did not affect the expression
level of h-prune (Fig. 2E). Since it has been suggested that the
formation of large focal adhesions is due to the reduced turn-
over of adhesions (36), the effects of GSK-3 and h-prune on
FIG. 3. Involvement of h-prune in cell migration. (A) Left panel,
the lysates of HeLa S3 cells transfected with control siRNA or siRNA
for h-prune were probed with the indicated antibodies. Right panel,
HeLa S3 cells transfected with control siRNA or siRNA for h-prune
were subjected to the Transwell migration assay. (B) Left panel, the
lysates of HeLa S3 cells expressing Myc-h-prune(333-453) were probed
with anti-h-prune or anti-GSK-3 antibody (lanes 1 to 4). The same
lysates were immunoprecipitated with anti-GSK-3 antibody (lanes 5
to 8). Right panel, two different clones (C1 and C33) of HeLa S3 cells
stably expressing Myc-h-prune(199-453) were subjected to the Trans-
well migration assay. Cells transfected with vectors alone were used as
a control (Mock). The results shown are means 	 standard errors of
the means from three independent experiments. IP, immunoprecipi-
tation.
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FIG. 4. Localization of h-prune and GSK-3 to focal adhesions. (A) HeLa S3 cells were stained with anti-GSK-3 (a), anti-h-prune (d), or
antipaxillin (e) antibody or phalloidin-fluorescein isothiocyanate (FITC) (b). Merged images are shown in panels c and f. The regions in white
boxes are shown magnified. (B) C57MG cells were stained with anti-GSK-3 (a and d), anti-pY216-GSK-3 (g), anti-h-prune (j, m, and p), or
antipaxillin (e and n) antibody or phalloidin-FITC (b, h, and k). To show the localization of GSK-3 and h-prune simultaneously, anti-GSK-3
antibody was labeled with a Zenon labeling kit (Molecular Probes) (q). Merged images are shown in panels c, f, i, l, o, and r. The regions in white
boxes are shown magnified. Scale bar, 10 m. (C) The lysates of C57MG cells (lane 1) were immunoprecipitated with anti-h-prune antibody, and
the immunoprecipitates were probed with the indicated antibodies (lane 3). The immunoprecipitates obtained with anti-GFP antibody were used
as a control (lane 2). (D) The lysates of COS cells expressing deletion mutants of h-prune were probed with anti-Myc antibody (lanes 1 to 5). The
same lysates were immunoprecipitated with antipaxillin antibody, and the immunoprecipitates were probed with the indicated antibodies (lanes
6 to 10). The results shown are representative of three independent experiments. (E) HeLa S3 cells expressing Myc-h-prune were lysed, and the
lysates were incubated with 0.1 M GST-paxillin or GST immobilized on glutathione-Sepharose. After GST-paxillin or GST was precipitated by
centrifugation, the precipitates were probed with the indicated antibodies. IP, immunoprecipitation; Ab, antibody; Mock, control.
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FIG. 5. Involvement of GSK-3 and h-prune in dynamics of focal adhesions. (A) Upper panel, monolayers of C57MG cells on collagen-coated
coverslips were treated with 10 M SB216763 for 4 h. After wounding, wounded monolayers were allowed to heal for 12 h. Scale bar, 0.2 mm.
Lower panel, the length of the wounds was measured and expressed as a percentage of the initial distance at time zero. Open circles, dimethyl
sulfoxide (DMSO) treatment; filled circles, SB216763 (SB) treatment. The results shown are means 	 standard errors of the means from three
independent experiments. (B) C57MG cells treated with 10 M SB216763 (d to f, m to o) or 10 M dipyridamole (Dip) (g to i) were wounded.
Six hours after wounding, the cells were stained with antipaxillin (a, d, and g), antivinculin (j and m), or anti-h-prune (b, e, h, k, and n) antibody.
Merged images are shown in panels c, f, i, l, and o. (C) HeLa S3 cells transfected with the siRNA for GSK-3 (d to f and j to l) were wounded.
Twelve hours after wounding, the cells were stained with antipaxillin (a and d), antivinculin (g and j), or anti-h-prune (b, e, h, and k) antibody.
Merged images are shown in panels c, f, i, and l. Scale bar, 10 m. The results shown are representative of three independent experiments. (D and
E) Dynamics of GFP-paxillin in migrating NIH 3T3 cells treated with NaCl or LiCl (D) and those in HeLa S3 cells treated with the indicated
siRNAs (E) were visualized by time-lapse fluorescence microscopy. For each sequence, “t 0 min” is the frame in which the adhesions in the white
box were clearly observed. Scale bar, 5 m. (F) Rate constants for disassembly of GFP-paxillin in Fig. 5D and E were calculated. Quantifications
of GFP-paxillin disassembly show means 	 standard errors of the means. (G) The lamellipodium protrusion area was quantified in HeLa S3 cells
transfected with siRNA for GSK-3 or h-prune.
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the dynamics of focal adhesions were examined. We expressed
GFP-paxillin in NIH 3T3 and HeLa S3 cells and analyzed the
turnover of adhesions by live fluorescence imaging. At the cell
front, paxillin-containing adhesions disassembled as new adhe-
sions were formed near the leading edge (47). We measured
the rate constant of disassembly of paxillin-containing adhe-
sions in migrating NIH 3T3 cells and found that the average
rate of disassembly of GFP-paxillin from adhesion sites was
decreased in LiCl-treated cells (Fig. 5D and F) (see Video S1
in the supplemental material). The rate constants of disassem-
bly of paxillin in NaCl-treated and LiCl-treated cells were (13.5
	 4) 10
2 min
1 and (3.9	 0.4) 10
2 min
1, respectively.
We also found that the average rate of disassembly of GFP-
paxillin was reduced in the GSK-3 or h-prune knocked-down
cells (Fig. 5E and F) (see Video S2 in the supplemental ma-
terial). The rate constants of disassembly of paxillin in control
RNA-treated cells, GSK-3 knocked-down cells, and h-prune
knocked-down cells were (9.3	 1.4) 10
2 min
1, (3.4	 0.6)
 10
2 min
1, and (3.4 	 0.5)  10
2 min
1, respectively.
Lamellipodia at cell fronts were quantified by measuring the
area of protrusion. Lamellipodium protrusion formation was
reduced in GSK-3 or h-prune knocked-down cells (Fig. 5G).
Taken together, these results suggest that both GSK-3 and
h-prune are necessary for the efficient disassembly of adhesion
complexes.
Involvement of GSK-3 and h-prune in activation of FAK and
Rac. It has been reported that fibroblasts lacking FAK have a
reduced migration rate, with an increase in the number and
size of peripherally localized adhesions (22, 46). Several ty-
rosine residues become phosphorylated upon FAK activation
(34, 50). FAK is activated via autophosphorylation at Tyr397,
which is initiated by integrin engagement with its ligand (38).
Therefore, to examine the roles of GSK-3 and h-prune in the
activation of FAK, integrin was activated by attaching HeLa S3
cells to collagen. Phosphorylation of Tyr397 of FAK by stim-
ulation with collagen was decreased in GSK-3 and h-prune
knocked-down cells (Fig. 6A). Overexpression of h-prune(199-
453), which inhibits the interaction of GSK-3 with h-prune,
also suppressed the phosphorylation of Tyr397 of FAK (Fig.
6B). These results suggest that FAK acts downstream of
GSK-3. Consistent with these observations, expression of
FAKK578E/K581E, a constitutively active form of FAK (15), par-
tially rescued the inhibition of migration in GSK-3 knocked-
down cells (Fig. 6C). We next examined the roles of GSK-3
and h-prune in the activation of the small G protein Rac, which
stimulates cell migration. Collagen-dependent activation of
Rac was suppressed by reducing GSK-3 and h-prune in HeLa
S3 cells or by inhibiting GSK-3 activity (Fig. 6C). Rac was
activated by scratch wound, and this scratch-induced Rac ac-
tivation was also suppressed in HeLa S3 cells treated with
SB216763 (Fig. 6E). Taken together, these results suggest that
GSK-3 and h-prune regulate the activation of FAK and Rac
cooperatively.
Correlation of h-prune expression with tumor aggressive-
ness. h-prune has been reported to be highly expressed in
breast cancer (8, 55). We verified the expression of h-prune in
other tumors, such as colorectal and pancreatic cancers. Al-
though nonneoplastic colorectal epithelium contained some
h-prune-positive cells, cancer tissue gave stronger and more
extensive staining (Fig. 7A, a and b). Results were considered
positive when more than 50% of the cells were stained. In total,
27 (29.3%) of 92 colorectal cancer cases were positive for
h-prune. The positivity of h-prune was correlated with the
advanced T grade (depth of invasion), N grade (degree of
lymph node metastasis), and M grade (distant metastasis) (P
0.0132, P 0.0044, and P 0.0215, respectively; Fisher’s exact
test) (Table 1). Moreover, h-prune staining was observed more
frequently in stage III/IV cases than in stage I/II cases (P 
0.0044). Similar findings were also observed in the cases of
pancreatic cancer (18/42 cases were positive) except for M
grade cases (Fig. 7A, c and d, and Table 2). There was no
significant association between h-prune expression and M
grade, but pancreatic cancer cases with distant metastasis had
a tendency to express h-prune more strongly than those with-
out distant metastasis. These findings suggest that highly ex-
pressed h-prune could be generally related to higher tumor
aggressiveness.
As seen in other cell lines, h-prune was colocalized with
paxillin at focal adhesions in SW480 colorectal cancer-derived
cells (Fig. 7B). In scratch wound culture, treatment of SW480
cells with SB216763 or the siRNA for GSK-3 or h-prune
caused the accumulation of paxillin at the leading edge (Fig.
7C). Reduction of GSK-3 or h-prune by RNAi inhibited the
migration of SW480 cells (Fig. 7D). Consistent with previously
reported observations (8), dipyridamole suppressed the migra-
tion of SW480 cells (Fig. 7E). Furthermore, SB216763 and
dipyridamole inhibited cell migration additively (Fig. 7E), sug-
gesting that the combination of the inhibitors for the h-prune
PDE activity and GSK-3 kinase activity prevents invasiveness
or metastasis of colorectal cancer.
DISCUSSION
Cell migration is a complex cellular behavior that involves
protrusion and adhesion at the cell front and contraction and
detachment at the rear (36). In this study, we provide evidence
that GSK-3 and h-prune regulate cell migration cooperatively.
Treatment of the cells with GSK-3 inhibitors induced the dis-
sociation of GSK-3 from h-prune and suppressed cell migra-
tion. Knockdown of GSK-3 or h-prune by RNAi also inhibited
cell migration. Furthermore, expression of the C-terminal re-
gion of h-prune in HeLa S3 cells inhibited the interaction of
GSK-3 with h-prune and cell migration. Although we cannot
exclude the possibility that overexpression of the C-terminal
region of h-prune has other effects, these results suggest that
the binding of GSK-3 to h-prune is necessary for cell migra-
tion. Furthermore, inhibition of GSK-3 affected both hapto-
tactic and random migration. It has been suggested that hap-
totactic migration is more dependent on the ability of cells to
form adhesive contacts at the cell front and that random mi-
gration is more limited by the ability of cells to release adhe-
sions at the cell rear (20). Therefore, GSK-3 plays a role in the
assembly and/or disassembly of focal adhesions.
How do GSK-3 and h-prune regulate cell motility? GSK-3 or
h-prune knocked-down cells exhibited large focal adhesions.
Furthermore, reduction of GSK-3 or h-prune by RNAi im-
paired the disassembly of paxillin from focal adhesions. Similar
phenotypes of abnormal focal adhesions with reduced cell mi-
gration are observed in the fibroblasts from mice lacking FAK
(22). FAK activation, demonstrated by an increase in the phos-
phorylation of Tyr397 in the protein, is best understood in the
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context of the engagement of integrins at the cell surface (34).
Activation of FAK results in the recruitment of a number of
SH2-domain- and SH3-domain-containing proteins. Among
them, p130Cas and Crk are involved in cell migration (34).
Dominant negative Rac blocks the increased migration in re-
sponse to the expression of p130Cas and Crk, probably
through DOCK180, which suggests that Rac is an important
downstream effector of the FAK-Cas-Crk complex.
We showed that the phosphorylation of Tyr397 in FAK and
the activation of Rac induced by collagen are reduced in the
GSK-3 or h-prune knocked-down cells. Furthermore, treat-
ment with GSK-3 inhibitors or overexpression of the C-termi-
nal region of h-prune also showed the same results as those
obtained in the GSK-3 or h-prune knocked-down cells. It has
been demonstrated that FAK plays a prominent role in inte-
grin signaling and that Rac is required for adhesion turnover
(34, 39). Therefore, FAK and Rac could act downstream of
GSK-3 and h-prune. Consistent with these observations, ex-
pression of a constitutively active form of FAK rescued the
inhibition of cell migration in GSK-3 knocked-down cells al-
though it was partial. The phosphorylation of proteins by
GSK-3 at focal adhesions may be required to mediate the
integrin signal. The substrates of GSK-3 that regulate FAK
activity remain to be identified.
Several reports have shown that GSK-3 negatively regulates
cell migration. For example, integrin inhibits GSK-3 through
the activation of integrin-linked kinase and PKB/Akt, and ac-
tivation of PKB/Akt promotes cell migration (26). Further-
FIG. 6. Involvement of GSK-3 and h-prune in the activation of FAK and Rac. (A and B) FAK activation. HeLa S3 cells transfected with the
indicated siRNAs (A) or expressing Myc-h-prune(199–453) (B) were suspended in serum-free medium and were kept in suspension (Sus) or
replated onto collagen-coated dishes (Col). Top panel, the cells were lysed at 1 h after plating, and the lysates were probed with the phospho-
specific antibody to FAK pTyr397 (pY397 FAK) or anti-FAK antibody. Bottom panel, the FAK activity was measured as the ratio of phosphor-
ylated FAK (active FAK) to total FAK. (C) GFP or GFP-FAKK578E/K581E (sFAK) was expressed in NIH 3T3 cells transfected with siRNA for
GSK-3, and the cells were subjected to the Transwell migration assay. Migrated GFP-labeled cells were normalized with transfection efficiency.
Top panel, the protein levels of GFP-FAKK578E/K581E and GSK-3 were shown by anti-FAK and GSK-3 antibodies. Bottom panel, migration ability
of the cells used in this assay. (D) Rac activation. HeLa S3 cells were transfected with the indicated siRNAs or treated with the indicated GSK-3
inhibitors. The cells were replated onto collagen-coated dishes, and the lysates were incubated with GST-CRIB immobilized on glutathione-
Sepharose. Top panel, the total lysates and precipitates were probed with anti-Rac-1 antibody. Bottom panel, the Rac activity was measured as
the ratio of the amount of CRIB-bound Rac (active Rac) to that of Rac in total cell lysates (total Rac). (E) Multiple wounds were made several
times in HeLa S3 cells treated with 10 M SB216763 (SB). The Rac activity was measured at 4 h after wounding. DMSO, dimethyl sulfoxide.
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FIG. 7. Correlation of h-prune expression with tumor aggressiveness. (A) Immunohistochemical analyses of h-prune in human colorectal
cancer (a and b) and human pancreatic cancer (c and d). (a) Magnification, 13; (c) magnification, 33. Expression levels of h-prune in the
nontumor and tumor regions were compared. (b and d) Magnification, 135. The tumor regions were enlarged. (B) SW480 cells were stained with
antipaxillin (a) or anti-h-prune (b) antibody. The merged image is shown in panel c. (C) SW480 cells treated with 10 M SB216763 (d to f) or
transfected with the siRNA for GSK-3 (j to l) or h-prune (m to o) were wounded. Twelve hours after wounding, the cells were stained with
antipaxillin
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more, PKB/Akt promotes integrin recycling by inactivating
GSK-3 (37), and hypoxia-induced tumor cell invasion is medi-
ated by inhibiting GSK-3 (53). However, inhibition of GSK-3
has been demonstrated to prevent the accumulation of Rac at
lamellipodia and to inhibit epidermal growth factor-dependent
wound closure (29), consistent with our results showing that
GSK-3 positively regulates cell migration. Although the exact
reasons for the differences between our results and those of
others are not known, it has been demonstrated that GSK-3 is
rapidly and transiently activated, followed by its inhibition by
extracellular stimuli, including insulin and epidermal growth
factor, or cell adhesion (6, 31). Therefore, cell migration may
involve cyclic transient activation and inactivation of GSK-3 as
well as modulation of the cellular localization of GSK-3. Since
our results suggest that GSK-3 forms a complex with focal
adhesions through h-prune, the GSK-3 activity may be neces-
sary to trigger the integrin signal. Another possibility is that
GSK-3 binds to h-prune at a site other than focal adhesion. In
this model, when GSK-3 is inactivated by integrin, h-prune
dissociates from GSK-3 and locates to focal adhesions. Then,
h-prune may promote cell migration with GSK-3 after the
kinase activity is recovered.
We showed that h-prune overexpression in colorectal and
pancreatic cancers is correlated with the depth of invasion and
the degree of lymph node metastasis. Taken together with the
observations that h-prune is highly expressed in invasive breast
cancer (55), this suggests that h-prune might be used as a
marker for the identification of subsets of the cancer patients
with higher tumor aggressiveness. h-prune has cyclic nucleo-
tide PDE activity, and inhibition of the PDE activity by di-
pyridamole suppresses cell motility (8). Although a correlation
between an h-prune PDE activity and cellular motility has been
shown, GSK-3 did not affect the PDE activity of h-prune.
Inhibition of GSK-3 and h-prune additively suppressed the cell
migration of colon cancer cells, suggesting that h-prune regu-
lates cell motility by two different actions through the PDE
activity and the GSK-3 binding activity. Therefore, the identi-
fication of highly specific inhibitors of GSK-3 and h-prune
might be useful for developing medicines to prevent or treat
cancer metastasis.
It has been reported that Drosophila prune genetically inter-
acts with awdk-pn, which encodes a nucleotide diphosphate
kinase as well as mammalian nm23-H1 (4), and that h-prune
and nm23-H1 protein levels are unbalanced in sarcoma and
breast cancers (12), suggesting that h-prune may negatively
regulate nm23-H1 antimetastatic activity. These results are
consistent with the previous observations that nm23-H1 is
downregulated in certain cancer cells with high metastasis (33).
However, the expression levels of nm23-H1 show no relation-
ship with metastasis of other cancer cells, such as colorectal
cancer (17). Since we could not detect the presence of
nm23-H1 in the GSK-3 immune complexes (data not shown),
whether the complex of GSK-3, h-prune, and nm23-H1 is
present and whether this ternary complex is involved in cell
migration are not known.
Protein complexes containing GSK-3 regulate the functions
of GSK-3 in different subcellular locations. Frat-1, which is
known to be involved in the regulation of -catenin stability,
binds to GSK-3 and facilitates its nuclear export (13). p53
interacts with GSK-3 in the nucleus. This association activates
TABLE 1. Relation between h-prune expression and
clinicopathologic characteristics in colorectal cancer
Characteristica
No. of cases (%) with indicated
h-prune expression P value
Positive Negative
T grade
T1/2 3 (11.1) 24 0.0132
T3/4 24 (36.9) 41
N grade
N0 10 (17.9) 46 0.0044
N1/2 17 (47.2) 19
M grade
M0 22 (25.9) 63 0.0215
M1 5 (71.4) 2
Stage
I/II 10 (17.9) 46 0.0044
III/IV 17 (47.2) 19
a T1, tumor invades submucosa; T2, tumor invades muscularis propria; T3,
tumor invades through muscularis propria into subserosa or into nonperitone-
alized pericolic or perirectal tissue; T4, tumor directly invades other organs or
structures and/or perforates visceral peritoneum. N0, no regional lymph node
metastasis; N1, metastasis in one to three regional lymph nodes; N2, metastasis
in four or more regional lymph nodes. M0, no distant metastasis; M1, distant
metastasis.
TABLE 2. Relation between h-prune protein expression and
clinicopathologic characteristics in pancreatic cancer
Characteristica
No. of cases (%) with indicated
h-prune expression P value
Positive Negative
T grade
T1/2 2 (15.4) 11 0.0208
T3/4 16 (55.2) 13
N grade
N0 5 (25.0) 15 0.0334
N1 13 (59.1) 9
M grade
M0 10 (35.7) 18 0.2079
M1 8 (57.1) 6
Stage
I/II 10 (35.7) 18 0.2079
III/IV 8 (57.1) 6
a T1, tumor limited to pancreas (2 cm or less in greatest dimension); T2, tumor
limited to pancreas (more than 2 cm in greatest dimension); T3, tumor extends
beyond pancreas but without involvement of celiac axis or superior mesenteric
artery; T4, tumor invades celiac or superior mesenteric artery. N0, no regional
lymph node metastasis; N1, regional lymph node metastasis. M0, no distant
metastasis; M1, distant metastasis.
(a, d, g, j, and m) or anti-h-prune (b, e, h, k, and n) antibody. Merged images are shown in panels c, f, i, l, and o. Scale bar, 10 m. (D) Upper
panel, the lysates of SW480 cells transfected with the indicated siRNAs were probed with the indicated antibodies. Lower panel, SW480 cells
transfected with the indicated siRNAs were subjected to the Transwell migration assay. (E) SW480 cells treated with 10 M SB216763 and/or 10
M dipyridamole were subjected to the Transwell migration assay on collagen. SB, SB216763; Dip, dipyridamole; DMSO, dimethyl sulfoxide. The
results shown are means 	 standard errors of the means from three independent experiments.
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GSK-3, and GSK-3 promotes the transcriptional and apoptotic
actions of p53 (45). Further studies to identify additional GSK-
3-binding proteins will be necessary to clarify how regulatory
mechanisms are integrated to achieve substrate-specific regu-
lation of GSK-3 activity.
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